provocative testing comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Insulin-like growth factor 1 is produced largely in the liver in response to growth hormone signaling. Its concentration shifts over days rather than minutes, which makes it practical for tracking changes across a study period. Interpretation still depends on age, nutritional status, and concurrent illness, all of which independently affect the marker. Reference ranges are therefore stratified, and comparisons are usually made within an individual over time rather than against a single population threshold.
Assays for these markers differ in calibration and antibody specificity, so results from different platforms are not always interchangeable. Reported values can shift when a laboratory changes method, even without any biological change. Studies that span long periods or multiple sites often need cross-validation of assays. This methodological variability is a recognized limitation when comparing findings across published reports, and it remains a topic of ongoing standardization work.
Measuring the effect of a growth hormone-releasing hormone analogue requires markers that reflect pituitary output rather than the peptide itself. The two most frequently used are growth hormone and insulin-like growth factor 1. Growth hormone fluctuates sharply across the day and responds to sleep, stress, and meals, so isolated readings can be difficult to interpret. Insulin-like growth factor 1 changes more slowly and is often treated as the more stable integrated marker of axis activity.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
| Property | Value | Notes |
|---|---|---|
| Primary marker | Insulin-like growth factor 1 | Slow-changing integrated indicator of axis activity |
| Secondary marker | Growth hormone | Pulsatile; requires repeated or timed sampling |
| Typical analytical method | Immunoassay | Antibody-based quantification in serum |
| Common sample matrix | Serum | Collected under standardized conditions |
| Key interpretation factor | Age-stratified reference ranges | Baseline marker concentrations shift with age |
Lyophilized tesamorelin is generally stored refrigerated at temperatures between 2 and 8 degrees Celsius. The solid form is comparatively stable when kept dry and protected from light. Moisture uptake can promote aggregation and degradation, so sealed containers with desiccant are common. Researchers typically avoid repeated temperature cycling, which may stress the peptide. Documentation accompanying reference materials usually specifies a shelf life under these conditions.
Once reconstituted, the peptide is handled as a solution and is less stable than the lyophilized powder. Aqueous solutions are commonly kept cold and used within a defined period. Buffer composition and pH influence degradation rates, with extremes of acidity or alkalinity accelerating hydrolysis. Preservatives may be added in multi-dose formats to limit microbial growth. Freezing and thawing of solutions is generally avoided because it can cause precipitation or loss of activity.
Quantitation of the peptide relies mainly on reversed-phase high-performance liquid chromatography with ultraviolet detection, typically at 214 nanometers, where the peptide bond absorbs. Identity is confirmed by mass spectrometry, most often electrospray ionization coupled to liquid chromatography, and by peptide mapping after enzymatic digestion. Because related impurities differ only slightly in sequence or modification, method development emphasizes resolution rather than speed. Purity is usually reported as a percentage of the main peak area, with individual impurities listed separately when they exceed a defined reporting threshold.
Stability testing examines how the molecule changes under controlled stress. Thermal stress, light exposure, and extremes of pH are applied separately so that each degradation route can be attributed to a specific cause. The main observed changes are oxidation, deamidation, and aggregation into dimers or higher-order species. Accelerated studies at elevated temperature are used to estimate behavior over longer periods, though such extrapolation carries uncertainty. For a lyophilized powder, residual moisture and the choice of bulking agent strongly influence how quickly these changes appear.
Practical handling centers on limiting moisture, oxygen, and temperature excursions. Lyophilized material is generally held at or below minus twenty degrees Celsius, protected from light and kept sealed until use. Once reconstituted, solutions are typically kept cold and used within a short window because hydrolysis and microbial growth both accelerate in liquid form. Repeated freeze-thaw cycles are avoided, since they promote aggregation. Vial contents should be inspected for particulates and clarity before analysis, and working aliquots are prepared to reduce the number of times the stock is opened.
Besides that, maintaining a prolonged strict oral hygiene through proper intrasulcular toothbrushing technique could promote the keratinisation of the sulcular epithelium through the elimination of the bacterial flora within the sulcus. However, the clinical significance of the keratinisation of sulcular epithelium remains questionable as its contribution to the strength of the semi-permeable barrier is minimal and inducing keratinisation is also suggested to interfere with the healing process in periodontitis or after surgery. Others also warn against keratinisation of the adjacent junctional epithelium which could compromise its attachment to the tooth, defeating its purpose as a physical barrier.
==== Australia ==== 4-AcO-DMT can be considered an analog of psilocin making it a Schedule 9 prohibited substance in Australia under the Poisons Standard (October 2015). A Schedule 9 substance is a substance which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities.
== Awards == She was awarded the Agnes Fay Morgan Research Award in 1995. In 2019, Brodbelt received the Frank H. Field and Joe L. Franklin Award for Outstanding Achievement in Mass Spectrometry from the American Chemical Society. In 2023, she was named one of the "Mentors and Educators" in the Power List by the Analytical Scientist. In 2024, she was awarded the Thomson Medal by the International Mass Spectrometry Foundation.
The positions of president laboratory director and deputy laboratory director are filled by joint action of the chair and vice chair of the executive committee, with the University of California nominating the president and laboratory director and Bechtel nominating the deputy laboratory director. The current LLNS chairman is Norman J. Pattiz, founder and chairman of Westwood One, America's largest radio network, who also currently serves on the board of regents of the University of California. The vice chairman is J. Scott Ogilvie, president of Bechtel Systems & Infrastructure, Inc., who also serves on the board of directors of Bechtel Group, Inc. (BGI) and on the BGI Audit Committee.
Sources: en.wikipedia.org
=== Rare decay modes === Spontaneous fission accounts for about 1.1×10−9% of thorium-232 decays, corresponding to a partial half-life of about 1.3×1021 years. Double beta decay to uranium-232 is also theoretically possible. A 2020 experimental search set lower half-life limits for such decays to excited states of uranium-232.
Abbi Jacobson as Shira Schwooper, the middle of the Schwooper children, and sole daughter of Naomi and Elliot. Born in August 1984, Shira is a lesbian and is married to Kendra, with whom she raises twin boys, Walter and Benjamin, and lives in Oakland, California. Shira is blunt, sardonic, stubborn, and easily holds grudges, but she’s nonetheless still compassionate and loves her family, and has a loving healthy relationship with her wife. As a child, Shira was best friends with Rachel "Baby" Feldstein, and had a romantic relationship with Rachel in high school. However, after catching her making out with a man, Shira discovers Rachel saw her as a fling and feels betrayed, which ends their friendship. Shira cannot conceive children due to primary ovarian insufficiency, so Kendra bears the couple's children. Nicole Byer as Kendra Hooper, a lesbian and Shira's wife, who converts to Judaism as an adult after lying about being Jewish to cover up for a work absence during Rosh Hashanah. Born in 1982, Kendra is more grounded than her wife and loves her in spite of her stubborn tendencies. Kendra works as a senior manager for B.J Banana Fingers, a children's entertainment fast-food chain similar to Chuck E. Cheese. She gained her role due to her being a former workaholic who over-exerted herself—a habit she picked up from her father—after being accepted into a managerial training program when she was a floor manager. Kendra fired an employee who helped her as a child in order to gain a higher position by setting her up, which Kendra will have to live with.
== Insect-based pet food products on the market == As of August 5, 2021, AAFCO (Association of American Feed Control Officials) has voted to include adult dogs in the ingredient definition for whole dried black soldier fly larvae and black soldier fly larvae meal. This approval allows for the sale of BSF based dog food and treats in the United States. As of June 2023, according to a review of the market by leading BSF producer Protix there are over 43 brands worldwide marketing insect-based pet foods. 35 of these are in Europe. An example of a European brand developing complete dog and cat diets and treats using BSF in European, Asian and North American markets is YORA, another example of a brand making BSF treats in the US and Canada is ALT-PRO Advantage (formerly known as HOPE Pet Food).
Sources: en.wikipedia.org
July 1971: The association "Choisir la cause des femmes" is created — with philosopher Simone de Beauvoir and lawyer Gisèle Halimi — to demand the repeal of the 1920 law criminalizing abortion. January 3, 1972: Law on parentage. It opens the right for the mother to challenge, under certain conditions, the presumption of the husband's paternity. January 3, 1972: Law on the stay-at-home mother's allowance. April 24, 1972: Decree applying Article 4 of Law 67-1176 of December 28, 1967, on birth control and repealing Articles L. 648 and L. 649 of the Public Health Code. July 13, 1972: Law establishing the general status of military personnel; access to military careers is not subject to sex-based discrimination. August 16, 1972: Decree on the specific status of the corps of national police inspectors, in which women are allowed to apply. December 22, 1972: Law affirming the principle of equal pay between genders. January 2, 1973: Law on the Labor Code, which updates it and includes provisions on women's work. January 9, 1973: Law amending and supplementing the French Nationality Code and concerning certain provisions related to French nationality; it notably authorizes the transmission of nationality by the mother to her child, whether the child is "legitimate or illegitimate." March 23, 1973: Decree establishing the special status of female military corps.
CAL interdentally is >2mm on at least 2 non-adjacent teeth CAL buccally/orally is >3mm with pocket depths of >3mm on at least two teeth. As periodontitis is not the sole cause of clinical attachment loss, any CAL attributed to the following factors is not considered during diagnosis.
Both copies of the affected gene must carry the same mutation (homozygous condition) for a person to be affected by an autosomal recessive disorder. An affected person usually has unaffected parents, each of whom carries one mutated gene and one normal gene (heterozygous condition) and is referred to as a genetic carrier; they may not have any symptoms. When both parents have the sickle cell trait, any given child has a 25% chance of sickle cell disease; a 25% chance of no sickle cell alleles, and a 50% chance of the heterozygous condition (see diagram). There are several different haplotypes of the sickle cell gene mutation, indicating that it may have arisen spontaneously in different geographic areas. The variants are known as Cameroon, Senegal, Benin, Bantu, and Saudi-Asian. These are clinically important because some are associated with higher HbF levels, e.g., Senegal and Saudi-Asian variants, and tend to have milder disease. The gene defect is a single nucleotide mutation of the β-globin gene, which results in the amino acid glutamic acid being substituted by valine at position 6 of the β-globin chain. Haemoglobin S with this mutation is referred to as HbS, as opposed to the normal adult HbA. Under conditions of normal oxygen concentration, this causes no apparent effects on the structure of haemoglobin or its ability to transport oxygen around the body. However, the deoxy form of HbS has an exposed hydrophobic patch, which causes HbS molecules to form long, inflexible chains.
Sources: en.wikipedia.org
It varies slowly and reflects cumulative axis activity rather than momentary secretion. Growth hormone is released in pulses affected by sleep, stress, and meals, making single readings hard to interpret. The slower marker gives a more stable picture across a study period.
Assay calibration and antibody specificity differ between platforms, so identical samples can yield different numbers. A method change within one laboratory can shift results without any biological change. Cross-validation is often needed for multi-site work.
They capture only one moment in a pulsatile pattern and are strongly influenced by recent activity and meals. Repeated sampling or overnight profiles provide a more representative view. Provocative testing is an alternative when a dynamic response is of interest.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.